RT Book, Section
A1 Lebastchi, Amir H.
A1 Callender, Glenda G.
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145765162
T1 Natural History and Principles of Management of Pancreatic Neuroendocrine Tumors
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK accesssurgery.mhmedical.com/content.aspx?aid=1145765162
RD 2024/04/19
AB Pancreatic  neuroendocrine  tumors  (PNETs)  are  tumors  that  originate  from  the  islet  cells  of  the  pancreas  and  are  also  often  referred  to  as  islet  cell  tumors.  With  an  estimated  incidence  of  about  2.5  to  5  per  100,000  persons  per  year,  these  uncommon  tumors  represent  only  1%  to  2%  of  pancreatic  malignancies.1  In  contrast  to  pancreatic  adenocarcinoma,  the  incidence  of  PNETs  appears  to  have  increased  over  the  past  decades.2,3  Autopsy  studies  have  shown  that  small,  asymptomatic  PNETs  may  occur  in  as  many  as  10%  of  people.4,5  Thus,  increased  detection,  particularly  because  of  increased  imaging  and  advances  in  imaging  technology,  may  account  for  much  of  the  rise  in  the  incidence  of  PNETs.6-8